Baniak, Lynn M. http://orcid.org/0000-0003-2166-3615
Chasens, Eileen R.
Luyster, Faith S.
Strollo, Patrick J. Jr
Thunström, Erik
Peker, Yüksel
Funding for this research was provided by:
National Institutes of Health (HL82610)
Article History
Received: 17 May 2018
Revised: 11 September 2018
Accepted: 2 October 2018
First Online: 15 October 2018
Compliance with ethical standards
:
: All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements) or non-financial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this manuscript. However, Thunström received consultant fees from ResMed and Pfizer outside the submitted work. Strollo received institutional grants from Philips-Respironics, ResMed, Inspire Medical Systems, and National Football League PinMed, and advisory fees from ResMed, Emmi Solutions, Jazz Pharmaceuticals, Itamar Medical, Inspire Medical Systems, and Separation Design Group, all outside the submitted work. Peker received institutional grants from ResMed for the main RICCADSA trial, consultant fees from BresoTec, and lecture fees from ResMed and Philips-Respironics all outside the submitted work.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: For this type of study, formal consent is not required.